Euromedin Announces Two New Product Acquisitions

By European Medical Instruments Ltd euromedin, PRNE
Wednesday, April 13, 2011

Launch of Nogasin and Lactocaps to Follow Success of Popular Anti-snoring Product Asonor(R)

LONDON, April 14, 2011 - European Medical Instruments Ltd (Euromedin) today announces the
acquisition of Nogasin, for treatment against flatulence and bloating, and
Lactocaps, for those suffering from lactose intolerance, from Finnish
Pharmaceutical Verman. Both products are scheduled to launch in the UK later
this year, followed by France and Ireland.

This comes shortly after the success of the company's first product
launch, Asonor (R), a nasal spray that alleviates the main cause of snoring
and associated sleep disturbance. Asonor(R) has been available online in the
UK since March and can be purchased at www.asonor.co.uk.

Dr Jim Phillips, Chief Executive and co-founder of Euromedin said: "We
are encouraged to see such positive uptake of Asonor(R) in only its first
month since launch and are optimistic about the potential of our new
acquisitions. Our goals at Euromedin are not only to improve patient
treatment and care, but also to shake up the market dynamics through the
introduction of innovative products. We are committed to filling those gaps
in the market where there is a real need."

Nogasin is a convenient, simple capsule treatment which contains the
digestive enzyme alpha-galactosidase. This enzyme breaks down complex
carbohydrates in the intestine and helps to prevent both flatulence and
bloating.

Lactocaps is a Scandinavian lactase deficiency enzyme replacement
product, which will provide another treatment option to the estimated 5-20%
of the population who suffer from lactose intolerance

Asonor(R) is a clinically-proven anti-snoring spray that alleviates the
main cause of snoring and associated sleep disturbance. The product's
pump-action delivers a gentle spray of solution via the nasal passage to
lubricate the soft palate and lightly tighten the musculature of the throat,
significantly reducing interference with breathing. There is also an added
benefit of preventing the dry mouth that many snorers complain about in the
morning.

To find out more about Asonor and to purchase the product, visit
www.asonor.co.uk

About European Medical Instruments Ltd (Euromedin)

Euromedin was founded in 2008 with a mission to become a leading
distributor of medical devices, delivering outstanding results for its
customers. Its aim is to bring fresh thinking and innovative products to the
medical and healthcare marketplaces across the EU, delivering the very
highest levels of customer satisfaction. Euromedin is committed to improving
the quality and effectiveness of medical devices available to consumers and
healthcare professionals. To find out more, visit www.euromedin.com

About Verman

During the past few years Verman has been one of the fastest growing
pharmaceutical companies in Finland, with several market leaders in their
product categories. Verman operates in Northern Europe, the Baltic Countries
and in Russia. For more information, visit www.verman.fi/index.php

For more information or to arrange an interview, please contact: Claire Woods, Red Door Communications, T: +44(0)20-8392-8040, E: cwoods at rdcomms.com

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :